The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders (NCT07458100) | Clinical Trial Compass
RecruitingNot Applicable
The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders
China464 participantsStarted 2026-03-23
Plain-language summary
The goal of this clinical trial is to evaluate the effectiveness and cost-effectiveness of a digital mindfulness-based intervention in adults (aged 18-65) diagnosed with emotional disorders like depression or anxiety. The main questions it aims to answer are:
* Does adding a digital mindfulness intervention to usual care help people recover from emotional disorders faster and more sustainably over two years?
* Is this combined approach more cost-effective than usual care alone? Researchers will compare the group receiving the digital mindfulness intervention plus their usual treatment to the group receiving only their usual treatment to see if the intervention leads to better long-term recovery and represents good value for money.
Participants in the intervention group will:
* Attend eight weekly 2-hour online group mindfulness sessions.
* Use a WeChat mini-program for 49 days of guided mindfulness exercises and daily tasks.
* Patients who have not achieved reliable recovery after group retraining voluntarily participate in individual UP\&MIED counseling.
* Complete regular questionnaires and interviews over two years to track their progress.
All participants will continue to receive their usual medical care from their doctors throughout the study.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Age: 18-65 years.
✓. Diagnosed with an emotional disorder by a outpatient psychiatrist, including depressive disorders, anxiety disorders (e.g., generalized anxiety disorder, panic disorder, agoraphobia, social anxiety disorder), obsessive-compulsive disorder, post-traumatic stress disorder, and eating disorders (e.g., anorexia nervosa, bulimia nervosa).
✓. Symptom severity meeting the threshold: PHQ-9 score ≥10 or GAD-7 score ≥8.
Exclusion criteria
✕. Current diagnosis of psychotic disorders or bipolar disorder.
✕. Current organic mental disorders, pervasive developmental disorders, severe cognitive impairment, or substance use disorders.
✕. Current suicide risk (PHQ-9 item 9 score \>2).
✕. Antisocial personality disorder.
✕. Severe medical illnesses that may affect intervention participation or require recent hospitalization.
✕
What they're measuring
1
Time to Reliable Recovery
Timeframe: at baseline (T0), at week 3(T1) and at week 5 (T2), at post-intervention (T3), and at 6(T4), 12(T5), 18(T6), and 24(T7) months after the intervention